These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8157017)

  • 1. Surfactant replacement therapy: a new risk factor in developing retinopathy of prematurity?
    Termote JU; Schalij-Delfos NE; Wittebol-Post D; Brouwers HA; Hoogervorst BR; Cats BP
    Eur J Pediatr; 1994 Feb; 153(2):113-6. PubMed ID: 8157017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Less severe retinopathy of prematurity induced by surfactant replacement therapy.
    Termote J; Schalij-Delfos NE; Cats BP; Wittebol-Post D; Hoogervorst BR; Brouwers HA
    Acta Paediatr; 1996 Dec; 85(12):1491-6. PubMed ID: 9001664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinopathy of prematurity in surfactant treated infants.
    Rankin SJ; Tubman TR; Halliday HL; Johnston SS
    Br J Ophthalmol; 1992 Apr; 76(4):202-4. PubMed ID: 1390486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant replacement therapy and the prevalence of acute retinopathy of prematurity.
    Tubman TR; Rankin SJ; Halliday HL; Johnston SS
    Biol Neonate; 1992; 61 Suppl 1():54-8. PubMed ID: 1391267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine surfactant therapy and retinopathy of prematurity.
    McGinnity FG; Girschek PK; Morin JD; O'Donoghue EP; Dunn MS
    J Pediatr Ophthalmol Strabismus; 1994; 31(4):238-41. PubMed ID: 7807300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in neonatology: less severe retinopathy of prematurity?
    Termote J; Schalij-Delfos NE; Brouwers HA; Donders AR; Cats BP
    J Pediatr Ophthalmol Strabismus; 2000; 37(3):142-8. PubMed ID: 10845414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calf lung surfactant extract prophylaxis and retinopathy of prematurity.
    Repka MX; Hudak ML; Parsa CF; Tielsch JM
    Ophthalmology; 1992 Apr; 99(4):531-6. PubMed ID: 1584570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinopathy of prematurity in a controlled trial of prophylactic surfactant treatment.
    Pennefather PM; Tin W; Clarke MP; Fritz S; Strong NP
    Br J Ophthalmol; 1996 May; 80(5):420-4. PubMed ID: 8695563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized clinical trial of surfactant prophylaxis in retinopathy of prematurity.
    Holmes JM; Cronin CM; Squires P; Myers TF
    J Pediatr Ophthalmol Strabismus; 1994; 31(3):189-91. PubMed ID: 7931953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of surfactant replacement therapy for preterm neonates with respiratory distress syndrome in low- and middle-income countries: a systematic review.
    Sankar MJ; Gupta N; Jain K; Agarwal R; Paul VK
    J Perinatol; 2016 May; 36 Suppl 1(Suppl 1):S36-48. PubMed ID: 27109091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant replacement therapy in developing countries.
    Vidyasagar D; Velaphi S; Bhat VB
    Neonatology; 2011; 99(4):355-66. PubMed ID: 21701209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors in the development of mild and severe retinopathy of prematurity.
    Akkoyun I; Oto S; Yilmaz G; Gurakan B; Tarcan A; Anuk D; Akgun S; Akova YA
    J AAPOS; 2006 Oct; 10(5):449-53. PubMed ID: 17070481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinopathy of prematurity and antenatal corticosteroids. The Italian ROP Study Group.
    Console V; Gagliardi L; De Giorgi A; De Ponti E
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():75-9. PubMed ID: 10021720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory distress syndrome in Curaçao. Conventional versus surfactant treatment.
    Verhagen AA; van der Meulen GN; Wiersma HE; Keli SO; Angelista IR; Muskiet FD; van Meer H
    West Indian Med J; 2002 Jun; 51(2):68-73. PubMed ID: 12232944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinopathy of Prematurity among Very-Low-Birth-Weight Infants in Korea: Incidence, Treatment, and Risk Factors.
    Hwang JH; Lee EH; Kim EA
    J Korean Med Sci; 2015 Oct; 30 Suppl 1(Suppl 1):S88-94. PubMed ID: 26566363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of retinopathy of prematurity in premature infants weighing less than 1600 g.
    Liu PM; Fang PC; Huang CB; Kou HK; Chung MY; Yang YH; Chung CH
    Am J Perinatol; 2005 Feb; 22(2):115-20. PubMed ID: 15731992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. American and Canadian Exosurf Neonatal Study Groups.
    Courtney SE; Long W; McMillan D; Walter D; Thompson T; Sauve R; Conway B; Bard H
    J Pediatr; 1995 May; 126(5 Pt 2):S43-52. PubMed ID: 7745510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
    Yost CC; Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD001456. PubMed ID: 10796266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe retinopathy of prematurity in extremely low birth weight infants after short-term dexamethasone therapy.
    Ramanathan R; Siassi B; deLemos RA
    J Perinatol; 1995; 15(3):178-82; quiz 183-4. PubMed ID: 7666264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Less invasive surfactant administration in extremely preterm infants: impact on mortality and morbidity.
    Klebermass-Schrehof K; Wald M; Schwindt J; Grill A; Prusa AR; Haiden N; Hayde M; Waldhoer T; Fuiko R; Berger A
    Neonatology; 2013; 103(4):252-8. PubMed ID: 23446061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.